While it offers potential benefits, the timing of its administration can significantly impact its effectiveness and the management of side effects
We know stopping these drugs altogether results in rebound weight gain
Bariatric Surgery: Patients may lose up to 60% of excess weight six months after surgery and 77% of excess weight as early as 12 months after surgery
General Information About FOXO4-DRI Peptide FOXO4-DRI peptide is a synthetic version of the FOXO4 protein that contains D-amino acids instead of L-amino acids
* Average of AM and PM rTNSS for each day (maximum score = 12) and averaged over the 2-week treatment period
100% achieved 5% Weight loss was dose-dependent: 4mg (-17.1%), 8mg (-22.8%), 12mg (-24.2%) at 48 weeks Results appeared early (visible by week 4) and continued throughout the 48-week trial Beyond weight: significant improvements in blood pressure, lipids, liver fat, and glycemic control Investigational Drug: Retatrutide is not FDA-approved